UpHealth, Inc. provided unaudited earnings guidance for the year ended December 31, 2022. For the year, the company expects revenue to be between $205 million to $233 million, a 38% to 56% growth rate. Loss from operations to be between $4 million to $2 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 USD | -3.58% | +10.39% | +130.94% |
03-21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | UpHealth, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+130.94% | 10.25M | |
-10.45% | 25.14B | |
+16.71% | 22.32B | |
-4.41% | 2.28B | |
-22.47% | 1.94B | |
-33.01% | 1.84B | |
-20.50% | 1.26B | |
+0.32% | 1.26B | |
-3.47% | 1.24B | |
+9.11% | 1.08B |
- Stock Market
- Equities
- UPHL Stock
- News UpHealth, Inc.
- UpHealth, Inc. Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022